DANIEL TOMLINSON: Open Payments
NPI 1255722104 · WEST BLOOMFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 72 payments from 13 companies in 2025. Trend: 2023 $1,055 · 2024 $1,419 · 2025 $1,193
Food & beverage: $1,065Education: $128
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $237 |
| ABBVIE INC. | 10 | $182 |
| GENZYME CORPORATION | 6 | $181 |
| Galderma Laboratories, L.P. | 11 | $181 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $110 |
| Incyte Corporation | 4 | $89 |
| UCB, Inc. | 3 | $82 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Journey Medical Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, OPZELURA, NEMLUVIO, Bimzelx, LIBTAYO.
Industry payments across MI — which companies pay providers there.
